Drug Shortage Report for TEVA-CEPHALEXIN 125

Last updated on 2020-11-07 History
Report ID 123732
Drug Identification Number 00342106
Brand name TEVA-CEPHALEXIN 125
Common or Proper name CEPHALEXIN SUSP 125MG/5ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEPHALEXIN
Strength(s) 125MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100 & 150ml
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-03
Estimated end date 2020-11-30
Actual end date 2020-11-06
Shortage status Resolved
Updated date 2020-11-07
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-11-07 English Compare
v7 2020-11-06 French Compare
v6 2020-11-06 English Compare
v5 2020-10-30 French Compare
v4 2020-10-30 English Compare
v3 2020-09-04 English Compare
v2 2020-09-03 French Compare
v1 2020-09-03 English Compare